Patent · US Active

Influenza vaccines

US10251947B2 · kind B2 · utility

0Cited by
19References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2015
Grant dateApr 9, 2019
Priority date
Expiry dateJun 19, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16234
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a method for the treatment or prevention of an influenza virus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of a gamma-irradiated influenza virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.